Peter Mac - Peter MacCallum Cancer Centre
  • Australia’s only public hospital solely dedicated
    to cancer treatment, research and education
  • Research Home
  • A-Z index

Research

  • Laboratory Research
  • Clinical Research
  • About Us
  • Our Achievements
  • Education and Careers
  • Supporting Research
 
  • Research Publications
  • Research Reports
  • Our Funding
  • Information sheets
  • Forefront Newsletter
  • Research News and Events
    • The first Australian p53 workshop
    • Prof Joe Sambrook Leadership & Innovation Award
    • ACRF Victorian Centre for Functional Genomics in Cancer Opens at Peter Mac
    • Peter Mac Scores A Double In NHMRC Awards
    • New combined therapy for late stage multiple myeloma patients
    • 2009 GSK Research Excellence Award
    • Prof Mark Smyth Awarded Australia Fellowship
    • ACRF Awards Peter Mac $2.5 Million Grant
    • Great turnout for 2nd Peter Mac Public Lecture
    • Dr Wen Qiu wins 2011 Premier's Award
    • Prof David Bowtell defining new types of ovarian cancer
    • 2010 Research Report
    • 3rd annual Sir Peter MacCallum public lecture: your questions answered
    • Turning T-cells into torpedoes: unlocking the power of the immune system
    • Gene discovered that could see common household drugs harnessed to fight cancer spread
    • Clinical trials for new drug to protect bone marrow stem cell transplants in cancer patients a step closer

Research News and Events

  • Research Home
  • >
  • Our Achievements
  • >
  • Research News and Events

Research News and Events - Research at Peter Mac

News and Events

A place for discovery: 2012 Peter Mac Research Report now available

27 Mar 2013

A place for discovery: 2012 Peter Mac Research Report now available

Featuring Associate Professor Ross Hannan on the cover, the 2012 Peter Mac Research Report is now available online.

Associate Professor Hannan was integral to one of Peter Mac's biggest research stories of 2012: his theory that ribosome biogenesis can be targeted in pre-clinical models to selectively kill cancer cells, while sparing healthy cells, led to the development of a world-first compound that is being tested in clinical trials at Peter Mac this year.

The report features a new 'Scope of research at Peter Mac' diagram, crystallising the work involved in enabling and conducting research at Peter Mac, directly informing more effective treatments and improved care for people with cancer, their families and carers.

previous | next

Printer friendly page

Media releases
→


  • Peter MacCallum Cancer Centre © 2009
  • Site map
  • Privacy
  • Contact us
digital presence bykomosion